Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1)

Blood - United States
doi 10.1182/blood.v128.22.4705.4705
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Gene Therapy Progress and Prospects: Gene Therapy for Severe Combined Immunodeficiency

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2003English

Correction:Occurrence of Leukaemia Following Gene Therapy of X-Linked SCID

Nature Reviews Cancer
Cancer ResearchOncology
2003English

The Clinical Spectrum of Hypomorphic IL2RG Severe Combined Immunodeficiency (SCID)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Characterization of an MDR1 Retroviral Bicistronic Vector for Correction of X-Linked Severe Combined Immunodeficiency

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1998English

Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

A Novel X-Linked Combined Immunodeficiency Disease.

Journal of Clinical Investigation
Medicine
1990English

Development of Severe Combined Immunodeficient (SCID) Pig Models for Translational Cancer Modeling: Future Insights on How Humanized SCID Pigs Can Improve Preclinical Cancer Research

Frontiers in Oncology
Cancer ResearchOncology
2018English

Trisomy X in a Female Member of a Family With X Linked Severe Combined Immunodeficiency: Implications for Carrier Diagnosis.

Journal of Medical Genetics
Genetics
1994English

279. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID)

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy